Logo image of XELB

XCEL BRANDS INC (XELB) Stock Fundamental Analysis

USA - NASDAQ:XELB - US98400M2008 - Common Stock

1.71 USD
-0.17 (-9.04%)
Last: 10/20/2025, 8:22:34 PM
1.562 USD
-0.15 (-8.65%)
After Hours: 10/20/2025, 8:22:34 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to XELB. XELB was compared to 119 industry peers in the Specialty Retail industry. XELB has a bad profitability rating. Also its financial health evaluation is rather negative. XELB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XELB had negative earnings in the past year.
XELB had a negative operating cash flow in the past year.
XELB had negative earnings in each of the past 5 years.
XELB had negative operating cash flow in 4 of the past 5 years.
XELB Yearly Net Income VS EBIT VS OCF VS FCFXELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

XELB has a Return On Assets of -48.91%. This is amonst the worse of the industry: XELB underperforms 91.60% of its industry peers.
The Return On Equity of XELB (-94.11%) is worse than 72.27% of its industry peers.
Industry RankSector Rank
ROA -48.91%
ROE -94.11%
ROIC N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
XELB Yearly ROA, ROE, ROICXELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 135.33%, XELB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of XELB has grown nicely.
The Profit Margin and Operating Margin are not available for XELB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 135.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
XELB Yearly Profit, Operating, Gross MarginsXELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

2

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
XELB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, XELB has less shares outstanding
Compared to 1 year ago, XELB has a worse debt to assets ratio.
XELB Yearly Shares OutstandingXELB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
XELB Yearly Total Debt VS Total AssetsXELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

XELB has an Altman-Z score of -2.75. This is a bad value and indicates that XELB is not financially healthy and even has some risk of bankruptcy.
XELB has a Altman-Z score of -2.75. This is amonst the worse of the industry: XELB underperforms 88.24% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that XELB is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.48, XELB perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -2.75
ROIC/WACCN/A
WACC10.22%
XELB Yearly LT Debt VS Equity VS FCFXELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

XELB has a Current Ratio of 0.59. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, XELB is doing worse than 91.60% of the companies in the same industry.
A Quick Ratio of 0.59 indicates that XELB may have some problems paying its short term obligations.
The Quick ratio of XELB (0.59) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
XELB Yearly Current Assets VS Current LiabilitesXELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

XELB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.29%, which is quite impressive.
XELB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.63%.
Measured over the past years, XELB shows a very negative growth in Revenue. The Revenue has been decreasing by -27.67% on average per year.
EPS 1Y (TTM)54.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-270%
Revenue 1Y (TTM)-42.63%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-55.28%

3.2 Future

The Earnings Per Share is expected to grow by 46.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, XELB will show a decrease in Revenue. The Revenue will decrease by -9.31% on average per year.
EPS Next Y50.56%
EPS Next 2Y46.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.67%
Revenue Next 2Y15.63%
Revenue Next 3Y-9.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XELB Yearly Revenue VS EstimatesXELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
XELB Yearly EPS VS EstimatesXELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
XELB is valuated cheaply with a Price/Forward Earnings ratio of 5.59.
Based on the Price/Forward Earnings ratio, XELB is valued cheaper than 97.48% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.18. XELB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 5.59
XELB Price Earnings VS Forward Price EarningsXELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XELB Per share dataXELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XELB's earnings are expected to grow with 46.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.07%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XELB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCEL BRANDS INC

NASDAQ:XELB (10/20/2025, 8:22:34 PM)

After market: 1.562 -0.15 (-8.65%)

1.71

-0.17 (-9.04%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/amc
Inst Owners14.68%
Inst Owner Change0%
Ins Owners32.49%
Ins Owner Change8.5%
Market Cap8.14M
Analysts82.5
Price Target6.46 (277.78%)
Short Float %2.43%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.03%
Min EPS beat(2)-3.39%
Max EPS beat(2)27.45%
EPS beat(4)3
Avg EPS beat(4)26.9%
Min EPS beat(4)-3.39%
Max EPS beat(4)54.75%
EPS beat(8)7
Avg EPS beat(8)36.96%
EPS beat(12)9
Avg EPS beat(12)23.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-36.32%
Min Revenue beat(2)-43.05%
Max Revenue beat(2)-29.58%
Revenue beat(4)1
Avg Revenue beat(4)-25.67%
Min Revenue beat(4)-43.05%
Max Revenue beat(4)7.72%
Revenue beat(8)1
Avg Revenue beat(8)-16%
Revenue beat(12)3
Avg Revenue beat(12)-8.58%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20.83%
PT rev (3m)-53.09%
EPS NQ rev (1m)-491.67%
EPS NQ rev (3m)-1283.33%
EPS NY rev (1m)0%
EPS NY rev (3m)2.63%
Revenue NQ rev (1m)-43.13%
Revenue NQ rev (3m)-58.18%
Revenue NY rev (1m)-19.28%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.59
P/S 1.41
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.24
EYN/A
EPS(NY)0.31
Fwd EY17.89%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS1.21
BVpS5.15
TBVpS-1.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.91%
ROE -94.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 135.33%
FCFM N/A
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.5%
Cap/Sales 0.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -2.75
F-Score3
WACC10.22%
ROIC/WACCN/A
Cap/Depr(3y)2.47%
Cap/Depr(5y)7.52%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-270%
EPS Next Y50.56%
EPS Next 2Y46.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.63%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-55.28%
Revenue Next Year11.67%
Revenue Next 2Y15.63%
Revenue Next 3Y-9.31%
Revenue Next 5YN/A
EBIT growth 1Y46.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year104.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.74%
OCF growth 3YN/A
OCF growth 5YN/A